Hashitoxicosis: A Case Report
DOI:
https://doi.org/10.66266/inajemd.v2i1.44Keywords:
Hashimoto’s thyroiditis, graves’ disease, hashitoxicosisAbstract
Hashimoto Thyroiditis with Grave’s disease/Hashitixicosis is found in some cases, snd this case repirt describes a case of a woman with Hashitoxicosis. A 27 year old woman came to polyclinic on 18th March 2024 with complain of a lump felt, fatique, constipation and weight loss two month before she had weight gain later without any treatment. She was compomentis, BP 149/90 mmHg, HR 87x/i, Wayne index 0, Billewicz score -22. TSH 93.40 mclU/mL and FT4 0.39 ng/dL, anti-TPO >1000 Iau/mL, TRAb 2.46 IU/L. Thyroid ultrasound showed toxic diffuse struma, thyroid scintigraphy revealed enlarge lobes with high and even distribution and capture of radioactivity with conclusion Toxic Diffuse Struma, and cytologic examination showed colloid goiter. Patient was diagnosed as Hashitoxicosis and has been treated with levothyroxine 100 mg once daily. This woman was diagnosed as Hashitoxicosis based on clinical features of hypothyroidism at admission to polyclinic following clinical features of hyperthyroidism initially without any treatment, with laboratory results showed hypothyroidism with the increased of antibody for Hashimoto Thyroiditis and Grave’s disease. Treatment with levothyroxine 100 mg once daily showed the decrease of TSH and normal FT4 level. We report a case of Hashitoxicosis based on clinical features of hypothyroid following hyperthyroidism initially, laboratory, thyroid ultrasound thyroid scintigraphy, and cytologic examination result. Treatment with levothyroxine showed improvement.
Downloads
References
1. Ragusa F, Fallahi P, Elia G, et al. Hashimoto’s thyroiditis: epidemiology, pathogenesis, clinic and therapy. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101367.
2. Mikulska AA, Karazniewicz-Lada M, Filipowicz D, et al. Metabolic characteristics of Hashimoto’s thyroiditis patients and the role of microelements and diet in disease management—An overview. Int J Mol Sci. 2022;23(12):6592.
3. Hu X, Chen Y, Shen Y, et al. Global prevalence and epidemiological trends of Hashimoto’s thyroiditis in adults: A
systematic review and meta-analysis. Front Public Health. 2022;10:978333.
4. Gonzalez-Aguilera B, Betea D, Lutteri L, et al. Conversion to Graves disease from Hashimoto thyroiditis: a study of 24 patients. Arch Endocrinol Metab. 2018;62(6):609-14.
5. Ahmad E, Hafeez K, Arshad MF, et al. Case report: Hypothyroidism conversion to hyperthyroidism: It’s never too late. Endocrinol Diabetes Metab Case Rep. 2018;2018:18-0044.
6. Klubo-Gwiezdzinska J, Wartofsky L. Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment. Pol Arch Intern Med. 2022;132(3):1-10.
7. Crooks J, Murray IPC, Wayne EJ. Statistical methods applied to the clinical diagnosis of thyrotoxicosis. Q J Med. 1959;28:211-34.
8. Billewicz WZ, Chapman RS, Crooks J, et al. Statistical methods applied to the diagnosis of hypothyroidism. Q J Med. 1969;38:255-66.
9. Lee SL. Hashimoto thyroiditis. National Institute of Diabetes and Digestive and Kidney Diseases. 2014;1–8.
10. Caturegli P, Remigius AD, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4-5):391-97.
11. Chandanwale SS, Nair R, Gambhir A, et al. Cytomorphological spectrum of thyroiditis: a review of 110 cases. J Thyroid Res. 2018;2018:1-7.
12. Bell L, Hunter AL, Kyriacou A, et al. Clinical diagnosis of Graves' or non-Graves' hyperthyroidism compared to TSH receptor antibody test. Endocr Connect. 2018;7(4):504-10.
13. Kahaly GJ, Bartalena L, Hegedus L, et al. 2018 European Thyroid Association guideline for the management of Graves' hyperthyroidism. Eur Thyroid J. 2018;7(4):167-86.
14. Giovanella L, Avram AM, Iakovou I, et al. EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy. Eur J Nucl Med Mol Imaging. 2019;46(12):2514-525.
15. Starrenburg-Razenberg AJ, Cabezas MC, Gan IM, et al. Four patients with hypothyroid Graves’ disease. Neth J Med. 2010;68(4):178-80.
16. Shrestha A, Adhikari N, Devkota S, et al. Fluctuating hyperthyroidism and hypothyroidism in Graves' disease: the swinging between two clinical entities. Cureus. 2022;14(8):e28293.
17. Shahbaz A, Aziz K, Umair M, et al. Prolonged duration of Hashitoxicosis in a patient with Hashimoto’s thyroiditis: a case report and review of literature. Cureus. 2018;10(6):e2842.
18. Bishay RH, Chen RCY. Hashimoto's thyroiditis and Graves' disease in one patient: the extremes of thyroid dysfunction associated with interferon treatment. Case Rep Endocrinol. 2016;2016:1-4.
19. Clifford L, Wakil A. Conversion of primary hypothyroidism to hyperthyroidism. J ASEAN Fed Endocr Soc. 2018;33(2):190-93.
20. Ralli M, Angeletti D, Fiore M, et al. Hashimoto’s thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev. 2022;21(10):103140.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 InaJEMD - Indonesian Journal of Endocrinology Metabolism and Diabetes
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain copyright and grant the Indonesian Journal of Endocrinology, Metabolism and Diabetes (InaJEMD) the right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
© Indonesian Journal of Endocrinology, Metabolism and Diabetes (InaJEMD). Published by the Indonesian Society of Endocrinology (PERKENI).
